Povidone iodine mouthwash, gargle, nasal spray to reduce nasopharyngeal viral load in patients with COVID-19
What The Study Did: Researchers in this randomized clinical trial investigated whether nasopharyngeal application of povidone iodine could reduce the viral load of patients with nonsevere COVID-19 symptoms.
Authors: Olivier Mimoz, M.D., Ph.D., University Hospital of Poitiers in Poitiers, France, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoto.2020.5490)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Authors: Olivier Mimoz, M.D., Ph.D., University Hospital of Poitiers in Poitiers, France, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoto.2020.5490)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2020.5490?guestAccessKey=c60aee4d-d4da-4df2-ad4e-9482ac6400c5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020421